Clinical Trial Update: Risk Factors for Pulmonary Hypertension of the Newborn

View source ↗

Summary

NHLBI-sponsored trial investigating risk factors for pulmonary hypertension of the newborn has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension of the Newborn

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Persistent Fetal Circulation Syndrome, Lung Diseases | Status: COMPLETED